We proposed to exploit hypoxia-inducible factor (HIF)-1alpha overexpression in prostate tumours and use this transcriptional machinery to control the expression of the suicide gene cytosine deaminase (CD) through binding of HIF-1alpha to arrangements of hypoxia response elements. CD is a prodrug activation enzyme, which converts inactive 5-fluorocytosine to active 5-fluorouracil (5-FU), allowing selective killing of vector containing cells.
Laure Marignol, Ruth Foley, Thomas Southgate, Mary Coffey, Donal Hollywood and Mark Lawler
Download Paper
XBeam V2: FDA-Approved Treatment Planning Software
The Fastest, Safest Way to Plan Superficial & Orthovoltage Treatment XBeam V2 is the revolutionary, FDA 510(k)-cleared dose planning software designed to automate planning, eliminate risk, and seamlessly integrates with the Concerto system, Xstrahl’s clinical...
